GALWAY, IRELAND--January 26, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Germany's CureVac wants to accelerate the development of its potential COVID-19 vaccine by recruiting pharmaceutical major Bayer to help get it ready for mass rollout. Within this article: Details CureVac/Bayer alliance, progress of potential COVID-19 vaccine in testing, deal with the EC, related vaccines that have received approval
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
